Form 4: Procter & Gamble Executive Exercises Stock Options and Sells Shares
SEC Form 4 Filing
Gary A. Coombe, CEO Grooming at Procter & Gamble, exercised stock options and sold shares of common stock on August 8, 2024.
Summary
- On August 8, 2024, Gary A. Coombe, CEO Grooming at Procter & Gamble, exercised stock options to acquire 50,000 shares of common stock at a price of $91.07 per share.
- Simultaneously, Coombe sold 50,000 shares of common stock at a weighted average price of $171.0442, with the price ranging from $170.88 to $171.30.
- Following these transactions, Coombe directly owns 36,907.5637 shares of Procter & Gamble common stock.
- Coombe also indirectly owns 462.4972 shares through a retirement plan trustee and 1,295.35 shares through an international stock ownership plan and pension plan in Switzerland.
- He also holds options to buy 47,847 shares of common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing insider transactions, which carries a neutral sentiment. It doesn't indicate positive or negative performance for the company.
Industry Context
This filing is a routine disclosure of insider transactions and doesn't necessarily reflect a broader trend in the consumer goods industry. It is common for executives to exercise stock options and sell shares for personal financial management.
Comparison to Industry Standards
- Executive compensation practices, including stock options, are common across large publicly traded companies like Procter & Gamble.
- Companies such as Unilever, Nestle, and Johnson & Johnson also utilize stock options as part of their executive compensation packages.
- The exercise and sale of shares by executives are typical events and are usually disclosed through SEC filings like Form 4.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders.
- Shareholders may be interested in insider transactions as an indicator of management's confidence in the company, but this single transaction is unlikely to be significant.
Key Dates
| Date | Description |
|---|---|
| 02/28/2020 | Date stock options became exercisable |
| 02/26/2027 | Expiration date of stock options |
| 08/08/2024 | Date of stock option exercise and share sale |
| 08/12/2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.